ProSciento and Tidepool Collaborate to Integrate Diabetes Device Data Aggregation Platform into Clinical Trials
SAN DIEGO, June 20, 2018 – ProSciento Inc., a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases, today announced a collaboration with […]
ProSciento Appoints Dr. Carine Beysen, Industry Expert in Stable Isotope Research, to Senior Scientific Team
SAN DIEGO, June 19, 2018 /PRNewswire/ – ProSciento, Inc., a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases, today announced the appointment […]
ProSciento to Present at the American Diabetes Association 78th Scientific Sessions
SAN DIEGO, June 13, 2018 – ProSciento, Inc., a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases, will present clinical research data […]
ProSciento Presents Scientific Data at the 2nd Annual Nash Summit
SAN DIEGO, April 19, 2018 – ProSciento, a full scope clinical R&D services provider focused exclusively on metabolic diseases, will present scientific data at the 2nd Annual NASH Summit in […]
ProSciento Expands Asia Pacific Operations with Office in Australia
SAN DIEGO, March 7, 2018 /PRNewswire/ – ProSciento, Inc., a full scope clinical R&D services provider focused exclusively on early phase clinical development programs in metabolic diseases, today announced the […]
ProSciento CEO to Present at the European Association for the Study of the Liver (EASL) NAFLD Summit
SAN DIEGO, November 6, 2017 – ProSciento Inc., metabolism-focused, full scope clinical R&D services provider, will present study results at this week’s European Association for the Study of the Liver […]
ProSciento Presents at the 53rd European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon
SAN DIEGO, September 9, 2017 – ProSciento Inc., metabolism-focused, full scope clinical R&D services provider, will present study results at this week’s at the 53rd European Association for the Study […]
ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment
Companies enter into an exclusive, multi-year partnership to employ non-invasive, lipidomics-based diagnostic testing to establish a database enriched for subjects with NAFLD/NASH SAN DIEGO and DERIO, SPAIN, June 7, 2017 […]
ProSciento Presents at the American Diabetes Association’s 77th Annual Scientific Sessions in San Diego
SAN DIEGO, June 6, 2017 – ProSciento Inc., metabolism-focused, full scope clinical R&D services provider, will present study results at this week’s American Diabetes Association (ADA) 77th Scientific Sessions, June […]
ProSciento and Antaros Medical Present Scientific Data at the 2nd International NASH Biomarkers Workshop
SAN DIEGO and GOTHENBURG, May 1, 2017 – ProSciento, a full scope clinical R&D services provider focused on diabetes, NASH and obesity, and Antaros Medical, an advanced clinical imaging research […]